FDA Issues Safety Alert on Weight-Loss Drug’s Kidney Risks
19/06/2026
FDA Updates Orlistat Warnings The FDA issued a drug safety communication approving a label change that warns about the risk
FDA Updates Orlistat Warnings The FDA issued a drug safety communication approving a label change that warns about the risk
Social media has been on trial for allegedly harming youth mental health, and tech companies have been facing uphill legal
Menaquinone-7 (MK-7) supplementation modestly slowed the progression of coronary artery calcification (CAC) for patients in the placebo-controlled VitaK-CAC trial. Among
Alert sobre fiebre del conejo Health officials sounded the alarm on the presence of tularemia, or “rabbit fever,” in northern
The FDA on Friday approved belzutifanopens in a new tab or window (Welireg) plus pembrolizumab (Keytruda, Keytruda Qlex) as adjuvant